Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bone Healing During Ninlaro Exposure. An Open Label Phase 2 Single Centre Clinical Trial

NCT04028115 is registered in ClinicalTrials.gov with Thomas Lund as lead sponsor.

NCT NCT04028115
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04028115 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bone Healing During Ninlaro Exposure. An Open Label Phase 2 Single Centre Clinical Trial
Lead sponsor
Thomas Lund
Phase
Phase 2
Overall status
Completed
Start date
October 24, 2019
Completion date
April 1, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma